Issue 3, 2015

trans-Platinum(ii) complex of 3-aminoflavone – synthesis, X-ray crystal structure and biological activities in vitro

Abstract

This paper describes the synthesis of trans-bis-(3-aminoflavone)dichloridoplatinum(II) (trans-Pt(3-af)2Cl2; TCAP) for use as a potential anticancer compound, and the evaluation of its structure by elemental and spectral analyses, and X-ray crystallography. The complex demonstrated a significant cytotoxic effect against human and murine cancer cell lines, as well as weaker toxicity towards healthy cells (human peripheral blood lymphocytes) in comparison with cisplatin. Various biochemical and morphological methods confirm that the proapoptotic activity of trans-Pt(3-af)2Cl2 is markedly higher than the reference cisplatin. Our results suggest that trans-Pt(3-af)2Cl2 may have a different antitumour specificity from that of cisplatin.

Graphical abstract: trans-Platinum(ii) complex of 3-aminoflavone – synthesis, X-ray crystal structure and biological activities in vitro

Supplementary files

Article information

Article type
Paper
Submitted
22 May 2014
Accepted
27 Jul 2014
First published
29 Jul 2014

Dalton Trans., 2015,44, 938-947

Author version available

trans-Platinum(II) complex of 3-aminoflavone – synthesis, X-ray crystal structure and biological activities in vitro

M. Fabijańska, K. Studzian, L. Szmigiero, A. J. Rybarczyk-Pirek, A. Pfitzner, B. Cebula-Obrzut, P. Smolewski, E. Zyner and J. Ochocki, Dalton Trans., 2015, 44, 938 DOI: 10.1039/C4DT01501K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements